胱硫醚：一种用于1p/19q共缺失型胶质瘤的光谱生物标志物。 - Suppr

Cystathionine: A Spectroscopic Biomarker for 1p/19q Codeleted Gliomas.

作者信息

Lin Alexander P

机构信息

From the Center for Clinical Spectroscopy, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Ave, BLI236C, Boston, MA 02115.

出版信息

Radiology. 2023 Sep;308(3):e232100. doi: 10.1148/radiol.232100.

DOI:10.1148/radiol.232100

PMID:37668521

Abstract

摘要

相似文献

Cystathionine: A Spectroscopic Biomarker for 1p/19q Codeleted Gliomas.

Radiology. 2023 Sep;308(3):e232100. doi: 10.1148/radiol.232100.

Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopy.

Neuro Oncol. 2019 Jun 10;21(6):765-774. doi: 10.1093/neuonc/noz031.

C-Methionine Integrated PET/MRI-Based Texture Analysis Features May Have a Potential Ability to Distinguish Oligodendroglioma (IDH-Mutant and 1p/19q-Codeleted) From Varied Gliomas.

Acad Radiol. 2020 Jul;27(7):e159-e167. doi: 10.1016/j.acra.2019.09.013. Epub 2019 Oct 11.

Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas.

Neuro Oncol. 2014 Mar;16(3):400-8. doi: 10.1093/neuonc/not227. Epub 2013 Dec 12.

Predicting 1p/19q codeletion status using diffusion-, susceptibility-, perfusion-weighted, and conventional MRI in IDH-mutant lower-grade gliomas.

Acta Radiol. 2021 Dec;62(12):1657-1665. doi: 10.1177/0284185120973624. Epub 2020 Nov 22.

T2/FLAIR-mismatch sign for noninvasive detection of IDH-mutant 1p/19q non-codeleted gliomas: validity and pathophysiology.

Neurooncol Adv. 2020 Jan 10;2(1):vdaa004. doi: 10.1093/noajnl/vdaa004. eCollection 2020 Jan-Dec.

Histopathological investigation of the 1p/19q-codeleted gliomas resected following alkylating agent chemotherapy.

J Neurooncol. 2021 Dec;155(3):235-246. doi: 10.1007/s11060-021-03855-y. Epub 2021 Oct 31.

Loss of H3K27 trimethylation is frequent in IDH1-R132H but not in non-canonical IDH1/2 mutated and 1p/19q codeleted oligodendroglioma: a Japanese cohort study.

Acta Neuropathol Commun. 2021 May 21;9(1):95. doi: 10.1186/s40478-021-01194-7.

CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.

Neuro Oncol. 2019 Dec 17;21(12):1519-1528. doi: 10.1093/neuonc/noz124.

MRI and CT Identify Isocitrate Dehydrogenase -Mutant Lower-Grade Gliomas Misclassified to 1p/19q Codeletion Status with Fluorescence in Situ Hybridization.

Radiology. 2020 Jan;294(1):160-167. doi: 10.1148/radiol.2019191140. Epub 2019 Nov 12.

引用本文的文献

Exploring the role of LOX family in glioma progression and immune modulation.

Front Immunol. 2025 Apr 9;16:1512186. doi: 10.3389/fimmu.2025.1512186. eCollection 2025.

Predictive machine learning models based on VASARI features for WHO grading, isocitrate dehydrogenase mutation, and 1p19q co-deletion status: a multicenter study.

Am J Cancer Res. 2024 Aug 25;14(8):3826-3841. doi: 10.62347/MZLF2460. eCollection 2024.

Optimization and validation of echo times of point-resolved spectroscopy for cystathionine detection in gliomas.

Cancer Imaging. 2024 Sep 2;24(1):118. doi: 10.1186/s40644-024-00764-x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Cystathionine: A Spectroscopic Biomarker for 1p/19q Codeleted Gliomas.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Cystathionine: A Spectroscopic Biomarker for 1p/19q Codeleted Gliomas.

作者信息

机构信息

出版信息

相似文献

引用本文的文献